ProQR Therapeutics N.V. Ordinary Shares (PRQR) is a publicly traded Healthcare sector company. As of May 21, 2026, PRQR trades at $1.51 with a market cap of $159.10M and a P/E ratio of 0.00. PRQR moved +0.00% today. Year to date, PRQR is -29.90%; over the trailing twelve months it is -18.75%. Its 52-week range spans $1.07 to $4.62. Analyst consensus is strong buy with an average price target of $8.20. Rallies surfaces PRQR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the latest PRQR stock research?
ProQR Therapeutics N.V. Ordinary Shares (PRQR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PRQR moved +0.00% today. Analyst consensus is strong buy.
ProQR Therapeutics N.V. Ordinary Shares (PRQR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PRQR moved +0.00% today. Analyst consensus is strong buy.
Does Rallies show live market data for PRQR?
Rallies combines live market context with ticker research for PRQR, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
